More than 130 suppliers

In-house tech support

Call +31 (0)26 326 44 50

Bio-Connect

Products
Products
Antibodies
Chemicals
Proteins / Signaling Molecules
Assays
DNA / RNA / Vectors
Cell Culture
Genome Editing and Engineering
Molecular Biology
Lysates / Extracts
Expression
Labware / Accesories
Body Products
Technique Specific Products
Arrays / Slides
Promotions
All product groups
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
Suppliers
Industries
Industries
Biotech, Pharma & CRO
Academia
Diagnostics
Environment
Food
Veterinary
All industries
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
News

Website
Tech support
About us
About us
Our company
Our team
Divisions
Vacatures
Events
Promotions
Support your research
For 15 years, we connect life science researchers specialized in the import and distribution of life science reagents from global suppliers.
How can we help?
FAQ
Contact

ProductsBack/Dalcetrapib [211513-37-0]

Dalcetrapib [211513-37-0]

Research Use Only

D0244

Estimated Purity≥98%

Product group Chemicals

Overview

Supplier
LKT Laboratories
Product Name
Dalcetrapib [211513-37-0]
Delivery Days Customer
7
Certification
Research Use Only
Estimated Purity
≥98%
Format
DMSO 78 mg/mL ; Ethanol 78 mg/mL ; Water Insoluble
Scientific Description
Cholesterol ester transfer protein inhibitor.; JTT-705, RO4607381
Storage Instruction
-20°C
UNSPSC
12352200

References

Schwartz GG, Olsson AG, Abt M, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Nov 29;367(22):2089-99. PMID: 23126252. Goldberg AS, Hegele RA. Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib. Drug Des Devel Ther. 2012;6:251-9. PMID: 23055695. Robinson JG. Dalcetrapib: a review of Phase II data. Expert Opin Investig Drugs. 2010 Jun;19(6):795-805. PMID: 20465364.